The largest database of trusted experimental protocols

Isoflurane

Manufactured by GE Healthcare
Sourced in United States

Isoflurane is a general anesthetic agent used in laboratory settings. It is a clear, colorless, and volatile liquid that is administered through inhalation. Isoflurane is primarily used to induce and maintain anesthesia in small animals, such as rodents, during surgical or experimental procedures.

Automatically generated - may contain errors

5 protocols using isoflurane

1

Isoflurane Exposure in Aged Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male Sprague-Dawley rats (n=144, 20 months of age and weighing 500–600 g) were purchased from the Dongchuang Laboratory Animal Center (Changsha, Hunan, China) and housed in standard barrier facilities. They were maintained under a 12-h light/dark cycle (lights on at 07:00) with food and water ad libitum. The animals had a recovery period of at least 7 days to adapt to their new environment before experiments began.
isoflurane exposure was performed as previously described (2 (link)). In a transparent anesthetic chamber, rats were exposed to 1.5% isoflurane (Baxter Healthcare, Deerfield, IL, USA) with 2 l/min of 100% oxygen (Beijing Millennium City Gas Sales Center, China) as the carrying gas, or to vehicle (2 l/min of 100% oxygen) for 4 h. At the outlet of the chamber, gas composition (the concentrations of isoflurane, oxygen, and carbon dioxide) within the chamber was continuously analyzed by a gas monitor (Datex-Ohmeda, Inc., Louisville, CO, USA). After anesthesia, the rats received 100% oxygen until they recovered complete consciousness. In a previous study, it has been shown that this anesthesia protocol does not cause significant changes in glucose or blood gas (1 (link)).
+ Open protocol
+ Expand
2

In Vitro Anesthesia Exposure Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Coverslips in 12-well plates were placed in identical air-tight, humidified chambers (Billups-Rothenberg, Del Mar, CA, USA) as previously described [43 (link)]. Isoflurane (Baxter Healthcare Cooperation, Deerfield, IL, USA) or sevoflurane (AbbVie Inc., North Chicago, IL, USA) were delivered using an agent-specific, calibrated inline vaporizer (SuperaVet, Vaporizer Sales and Services Inc., Rockmart, GA, USA), and were diluted in 5% CO2/95% O2 carrier gas. Controls for these experiments received 5% CO2/95% O2 carrier gas only. There was a 15-min equilibration period, which was required to achieve the correct concentration of Isoflurane or sevoflurane as measured by a 5250 RGM gas analyzer (Datex-Ohmeda, Madison, WI, USA). Then the sealed chambers were placed in an incubator to maintain temperature at 37 °C for the duration of anesthesia exposure. Isoflurane/sevoflurane concentration was periodically measured at the end of the experimental period to verify that it was appropriately maintained throughout the exposure.
The propofol exposure was done by adding pure 2,6-diisopropylphenol (Sigma Aldrich, Saint Louis, MO, USA) (1 nM, 2 nM, 4 nM) into experiment wells, and incubated at 37 °C for the duration of anesthesia exposure. The exposure was terminated by removing all the media and by adding a combination of previously-removed media without propofol and fresh media.
+ Open protocol
+ Expand
3

PET/CT Imaging of Tumor Xenografts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two tumor bearing mice were injected with 18F-2 (13.0 MBq in 80 and 100 μL PBS containing ≤ 5% ethanol, 1.3 and 1.9 nmol) via lateral tail vein. Anaesthesia was induced with 5% isoflurane (Abbott) in O2/air 5 min before PET/CT acquisition. Depth of anaesthesia and temperature were controlled as described by Honer et al. (Honer et al. 2004 (link)). PET/CT scans were performed under 2–3% isoflurane anaesthesia with a GE VISTA eXplore PET/CT tomograph. Static scans were carried out 120–150 min p.i. in two bed positions (15 min upper body followed by 15 min lower body) with tumor-bearing mice. Data were reconstructed by two-dimensional ordered-subset expectation maximization (2D OSEM). Region of interest analysis was conducted with the PMOD 3.3 software (PMOD, Switzerland). The xenograft, kidney and liver volumes of interest were drawn according to the PET/CT images and average background activity was estimated from a sphere with a volume of ca. 0.5 cm3 between the shoulder regions. Standardized uptake values (SUV) were calculated as a ratio of tissue radioactivity concentration (kBq/cm3) and injected activity dose per gram body weight (kBq/g) at the scan start. Percentage injected dose per gram of tissue (%ID/g) was calculated using SUV values: SUV / body weight [g] × 100% = %ID/g.
+ Open protocol
+ Expand
4

Rat Prostate and Testis Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were anesthetized by delivering isoflurane (GE Healthcare) to the respiratory tract of the rat using a vaporizer at 3% concentration. The testis and the genitourinary tract comprising the bladder, urethra, seminal vesicles, and ampullary gland were excised. The prostate was microdissected into individual lobes, and the lateral prostate was isolated and was cut into two portions. One portion was snap-frozen in liquid nitrogen and stored at −80 °C. The remaining prostate portion was fixed in 10% buffered formalin and was paraffin embedded. Testis was stored at 4 °C.
+ Open protocol
+ Expand
5

Zinc Deficiency and Esophageal Cancer Risk in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal protocols were approved by the Thomas Jefferson University Institutional Animal Care and Use Committee. Weanling male rats were randomly divided into 4 dietary groups (ZD3, ZD6, ZD12, and ZS, n = 47-49 rats/group) and were tail-tattooed for identification. ZD rats were fed ad libitum and ZS rats were pair-fed to ZD6 animals to match the decreased food consumption of ZD6 rats [38 (link)]. After 5 weeks, 12 rats per group were killed for evaluation of esophageal cell proliferation [38 (link)]. The remaining animals were divided into NMBA-treated groups (n = 25-27 rats/dietary group) and NMBA-untreated groups (10 rats/group). Carcinogen-treated rats were administered intragastrically 4 NMBA doses (2 mg/kg body weight), once a week for 4 consecutive weeks. NMBA-untreated groups received saline. The animals were weighed weekly and monitored daily. The study was concluded at 17 weeks after the 1st NMBA dose (22 weeks of ZD). At sacrifice, the animals were anesthetized by delivering isoflurane (GE Healthcare) to the respiratory tract of the rat using a vaporizer at 3% concentration. Blood was obtained from the retro-orbital venous plexus for serum preparation and subsequent Zn analysis. Whole esophagus was excised and longitudinally slit open. Tumors greater than 0.5 mm in diameter were mapped.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!